{"originalText": "，患者2014年3月无明显诱因上出现中下腹疼痛，较剧烈，每次持续2-3分钟，不伴放射痛，有反酸嗳气，患者食欲欠佳，进食油腻食物后即感恶心，无腹胀腹泻，无呕血黑便。于2014-4-1行PET-CT考虑为胃窦部MT伴胃周淋巴结转移；脂肪肝；肝左后叶上段及两肾囊肿；左肾小结石；2014-04-02在我院全麻上行胃癌根治术，毕II式远端胃。术中见腹腔无腹水，肝脏、腹盆腔大网膜无异常。胃窦部小弯侧直径2CM增厚区，未浸润浆膜，胃周围可见肝动脉旁3CM肿瘤结节，淋巴结明显肿大。，病理：(远端胃)下皮性恶性肿瘤，部分区为神经内分泌癌(G3，约占肿瘤体积40%)；部分为肉瘤样癌(约占肿瘤体积40%)；部分为管状腺癌，分化II级(LAUREN分型肠型，约占肿瘤组织20%)。癌组织浸润胃壁肌层。双切缘未见癌累及。检出大弯侧淋巴结8枚，均未见癌转移(0/8)；检出小弯侧淋巴结19枚，其中5枚见癌转移(5/19)，另见癌结节1枚；检出幽门上淋巴结12枚，其中3枚见癌转移(3/12)。免疫组化(2014-N3491)，:TP(60%+),TS(20%+),B-TUBULIN(30%+),KI67(60%+),TOPII-A(40%+),ERCC-1(-),C-MET(-),HER-2(0),CK广(神经内分泌癌及肠型腺癌区域100%++,肉瘤样癌区域约10%+),SYN(30%++),CHG(30%++),CD56(部分+)。 手术过程顺利。术后恢复良好。患者术后分期PT2N3M0 IIIA期，有术后辅助化疗指征，考虑患者术后病理提示部分神经内分泌癌、部分肉瘤样癌、部分管状腺癌，拟三药联合方案，于2014.5.12、2014.6.2、2014.6.23、2014.7.15行第1-4次EOX方案术后辅助化疗，，计划用药：表柔比星 50MG/M2，奥沙利铂 130MG/M2，希罗达 1000MG/M2 BID D1-14，，计算用药：表柔比星 76.605MG D1，奥沙利铂 199.173MG D1，希罗达 1532.1MG/M2 BID D1-14，，实际用药：表柔比星100MG D1，奥沙利铂 150MG D1，希罗达 1500MG BID D1-14 Q3W，期间于2014.7.15复查腹部CT未见明确复发转移灶。患者化疗耐受可，今日为行第5次辅助化疗治疗入院。患者患病以来，精神可，夜眠可，二便无殊，近期体重稳定。", "entities": [{"end_pos": 21, "label_type": "解剖部位", "overlap": 0, "start_pos": 18}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"end_pos": 73, "label_type": "解剖部位", "overlap": 0, "start_pos": 72}, {"label_type": "影像检查", "overlap": 0, "start_pos": 91, "end_pos": 97}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 100, "end_pos": 113}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 114, "end_pos": 117}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 118, "end_pos": 129}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 130, "end_pos": 135}, {"label_type": "手术", "overlap": 0, "start_pos": 153, "end_pos": 166}, {"end_pos": 172, "label_type": "解剖部位", "overlap": 0, "start_pos": 170}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 173}, {"end_pos": 178, "label_type": "解剖部位", "overlap": 0, "start_pos": 176}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 179, "end_pos": 182}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 189}, {"end_pos": 212, "label_type": "解剖部位", "overlap": 0, "start_pos": 210}, {"end_pos": 218, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 239, "end_pos": 331}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 337, "end_pos": 338}, {"end_pos": 359, "label_type": "解剖部位", "overlap": 0, "start_pos": 353}, {"end_pos": 382, "label_type": "解剖部位", "overlap": 0, "start_pos": 376}, {"end_pos": 417, "label_type": "解剖部位", "overlap": 0, "start_pos": 411}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 667, "end_pos": 673}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 674, "end_pos": 680}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 681, "end_pos": 687}, {"end_pos": 763, "label_type": "药物", "overlap": 0, "start_pos": 759}, {"end_pos": 776, "label_type": "药物", "overlap": 0, "start_pos": 772}, {"end_pos": 789, "label_type": "药物", "overlap": 0, "start_pos": 786}, {"end_pos": 820, "label_type": "药物", "overlap": 0, "start_pos": 816}, {"end_pos": 837, "label_type": "药物", "overlap": 0, "start_pos": 833}, {"end_pos": 854, "label_type": "药物", "overlap": 0, "start_pos": 851}, {"end_pos": 887, "label_type": "药物", "overlap": 0, "start_pos": 883}, {"end_pos": 900, "label_type": "药物", "overlap": 0, "start_pos": 896}, {"end_pos": 913, "label_type": "药物", "overlap": 0, "start_pos": 910}, {"label_type": "影像检查", "overlap": 0, "start_pos": 949, "end_pos": 953}]}
